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Abstract
Attention Deficit Hyperactivity Disorder with or without hyperactivity disorder 
is a neurobiological disorder that involves the interaction of the neuroanatomical 
and neurotransmitter systems. It is a developmental disorder of psychomotor skills 
that is manifested by impaired attention, motor hyperactivity and impulsivity. 
This disorder is characterized by early onset, the association of hyperactive and 
poorly coordinated behavior with marked inattention and lack of perseverance 
in performing tasks; and this behavior occurs in all situations and persists over 
time. This disorder is inappropriate for the child’s developmental age and mal-
adaptive. Disorders of neurotransmitter metabolism in the brain with discrete 
neurological changes can lead to behavioral difficulties and other psychological 
problems. Most children and adolescents with Attention Deficit Hyperactivity 
Disorder have comorbidities, often multiple comorbid conditions in the same 
person. Comorbidity was observed in both clinical and epidemiological samples. 
It is estimated that about two-thirds of children with this disorder have at least one 
other psychiatric disorder diagnosed. Symptoms persist and lead to significant dif-
ficulties in the daily functioning of the child, such as school success, social interac-
tions, family and social functioning, etc. Recent studies indicate the presence of 
various neuroophthalmological disorders in children and adolescents with ADHD. 
The most common comorbidities in children and adolescents with ADHD that will 
be covered in this chapter are autism spectrum disorder, mood disorder, anxiety, 
learning disabilities, conduct disorders, tics disorder and epilepsy.
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1. Introduction
ADHD is a neurobiological disorder that encompasses the specifics of neu-
rotransmitter metabolism brain, and the interaction of the neuroanatomical and 
neurotransmitter systems. It is a developmental disorder of psychomotor skills 
that is manifested by impaired attention, motor hyperactivity and impulsivity [1]. 
Disorders of neurotransmitter metabolism in the brain with discrete neurologi-
cal changes can lead to behavioral difficulties and other psychological problems. 
Behavioral disorders, secondary psychological problems, and interaction disorders 
with mild neurological symptoms may occur with this disorder [2]. To make a diag-
nosis, the symptoms must be frequent and severe than in children of comparable 
developmental level, and they must cause significant difficulties in the child’s daily 
functioning [3]. It is a behavioral disorder that makes it difficult for a child to focus 
on daily requirements and routines. These children and adolescents usually have 
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difficulty organizing, focusing, making realistic plans, and thinking before they do 
something. The group of authors considers that ADHD is a developmental disorder 
of lack of behavioral inhibition, which manifests itself as a developmentally inap-
propriate degree of inattention, excessive activity and impulsivity, and complicates 
self-regulation and organization of behavior in relation to the future [4]. The main 
symptoms of ADHD are developmentally inappropriate for the age of the child and 
these are developmentally inappropriate levels of poor attention, hyperactivity and 
impulsivity. The degree of intensity of symptoms can vary according to the age of 
the child. Symptoms are manifested in the form of inattention of the child, the child 
does not perform its tasks, cannot organize, easily distracted, loses school and other 
things, “forgetful”, avoids prolonged exertion.
The clinical picture in boys and girls differs in some aspects of the symptoms. 
Boys are more motor hyperactive and girls are more inattentive, as if “dreaming”; 
and their hyperactivity manifests itself as emotional and verbal (in the form of 
chatter, crying, etc.).
Data on the frequency of this disorder in developmental age differ depending on 
the applied methodology, age of the respondents, urban or rural region, number of 
persons providing data on the child’s behavior (only parents, only teachers or both 
parents and teachers and others). Symptoms of hyperactivity are manifested in such 
a way that the child fidgets, gets up and leaves the bench, cannot play or do a task 
in peace, talks a lot, runs and climbs excessively, is always ready to “go” and others. 
Symptoms of impulsivity in a child are manifested by the child not being able to 
wait his turn, interrupting others when they speak, giving hasty answers, behaving 
intrusively and the like. Due to the symptoms, these children achieve poorer success 
in school, they have difficulties in mastering the school program, although they 
are most often of normal intellectual potential. Most adolescents who had ADHD 
as children still have difficulties in schooling, social interactions, and often emo-
tional problems. Some adolescents may show irritability, poor school performance, 
disorganized learning, and poor communication with peers. ADHD always appears 
in early development, usually in the preschool period, and is most often noticed 
when a child starts school. This disorder usually lasts during schooling, and in some 
it continues into adulthood. Many people may experience improved activity and 
attention. Children with ADHD are often careless and impulsive so they are prone 
to accidents and injuries. These children often break the agreed rules and often have 
disciplinary difficulties. In relationships with adults, children with ADHD are often 
socially disinhibited, without caution and reserve, reckless behavior. Other children 
often avoid them, and are considered unpopular among peers, so they are often 
isolated.
The prevalence of ADHD is between 5 and 7% for children and between 3 and 
5% for adults [5]. According to systematic review and meta-analysis, prevalence 
of ADHD among school-aged children and adolescent vary from 2.2% to 17.8% 
worldwide [6]. According to epidemiological studies, ADHD in children is thought 
to continue in 50–80% of cases in adolescence and adulthood. This high prevalence 
is of concern because this disorder negatively affects all neurodevelopmental areas 
and the psychosocial interactions of affected individuals. The risk may increase if 
symptoms such as aggression and irritability or comorbidities, such as behavioral 
disorders, are present.
In researching this problem, there are certain challenges in estimating the 
incidence of ADHD, such as are ways to assess ADHD, diagnostic methods, source 
of information about the disorder, agreement among respondents assessing ADHD 
symptoms, conducting assessments in one or more settings, age range of respon-
dents, geographical location and characteristics of the community from which 
respondents originate [5].
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Many studies indicate that ADHD is more common in boys [7]. The prevalence 
in boys and girls varies in different studies, and generally is more likely to be diag-
nosed and treated in boys than in girls [8]. The ratios from the clinical samples are 
higher than the ratios from the population samples. Research in this area of devel-
opmental psychiatry is extensive with a steady increase in the number of authors 
and professional literature dealing with this issue.
2. Comorbidity
The term “comorbidity” was introduced into medicine by Feinstein in 1970 to 
denote those cases in which a particular clinical entity exists simultaneously in a 
patient during the clinical course of his underlying disease [9]. Psychiatric disorders 
may coexist with somatic disorders and/or other psychiatric disorders when refer-
ring to “psychiatric comorbidity”.
Different causes can lead to comorbidities, which can be accidental or the result 
of a combination of different risk factors; or two disorders may have the same or 
overlapping risk factors when one disorder causes the other; or there may be a 
multiform manifestation of one of the two basic disorders when the third - inde-
pendent – occurs disorder. Due to insufficient knowledge of the etiopathogenesis 
of psychiatric disorders, modern classification systems (DSM and MKB) apply a 
descriptive, categorical system that classifies psychiatric symptoms and behaviors 
into a large number of different diagnoses.
The disadvantage of classification systems is that they poorly recognize the 
specifics and needs of child and adolescent psychiatry. The diagnostic process in 
developmental psychiatry is based on descriptive facts that determine the type of 
disorder, with the use of comorbidities to correct the shortcomings of this diagnos-
tic process and to bring the diagnostic categories closer to the real clinical situation. 
These specifics are: symptomatic, developmental, environmental and prognostic. 
In developmental psychiatry, there are specific limitations in the external mani-
festation of symptoms, as well as in the possibility of insight into the existence of 
dependent symptoms. In child and adolescent psychiatry, there is the possibility of 
uneven development of basic developmental lines such as cognitive, emotional and 
social, especially during early childhood. In childhood, there is a clear dependence 
on past and current environmental conditions. Their interaction largely determines 
the manifestation of mental disorder at this age.
ADHD is one of the most common neurodevelopmental disorders in child and 
adolescent psychiatry and one of the most researched disorders in child psychia-
try. Previous research indicates the existence of high comorbidity between ADHD 
and other psychiatric disorders in childhood. The presence of comorbidities 
largely depends on: case definition, assessment methodology, and control group. 
Studies have shown a high comorbidity between ADHD and behavioral disorders 
in the form of opposition and defiance, depression and anxiety. Some mechanisms 
for comorbidity include shared risk factors, distinct subtypes and weak causal 
relationships [10].
A 2015 study by Masi et al. showed more than 2/3 of patients with ADHD have 
a psychiatric disorder associated. The most common comorbid diagnoses with 
ADHD during early childhood are oppositional defiant disorder, enuresis and 
language disorder, and anxiety and tics in the mid-school years. In adolescence are 
observed mood disorder and substance use disorder. Many children with ADHD 
have a specific learning disorder [11]. The same study estimates that oppositional 
defiant disorder is concomitant with ADHD in 25–75% of the cases, conduct 
disorder about one third of cases, 6–30% of ADHD children have major depression, 
ADHD
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more than 20% of bipolar disorder co-occur with ADHD; 87% of disruptive mood 
dysregulation disorder children had ADHD concomitantly; the prevalence of PTSD 
in children with ADHD is 5.2%; chronic tics disorder with ADHD is 55%; 85% of 
children with autistic spectrum disorder show a clinical picture of ADHD [11].
Barkley states that 67–80% of children diagnosed with ADHD who have been 
referred for clinical treatment have at least one more diagnosis, and almost half of 
them have two diagnoses [5]. Two-thirds of children with ADHD have at least one 
other psychiatric disorder diagnosed [12].














The presence of comorbidities is significant because it complicates the diagnostic 
process, affects the course, prognosis and therapeutic process. Assessment and sup-
port in comorbid disorders are often as important as the assessment and treatment 
of ADHD symptoms [12].
2.1 Comorbidity with behavioral disorders
Behavioral disorders in developmental age are characterized by persistent and 
repetitive patterns of dissocial, aggressive, or defiant behavior. These behaviors 
in their most pronounced form can have criminogenic characteristics and deviate 
significantly from the socially expected ones according to the age of the child. These 
disorders are often accompanied by an unfavorable psychosocial environment, 
unsatisfactory family relationships and school failure. They are more commonly 
observed in boys than in girls.
Opposition-defiant behavior usually occurs in younger children, who exhibit 
extremely defiant, provocative, and disobedient behavior, and some children 
also exhibit aggressive behaviors. Most authors believe that 45–84% of children 
and adolescents with ADHD also exhibit oppositional-defiant behavior [5]. The 
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Multimodal Treatment Study of ADHD found that about 62% of preschool children 
with ADHD and 59% of school children in the sample had oppositional-defiant 
behavior [5]. It is hypothesized that emotional dysregulation that occurs in children 
with ADHD may affect the occurrence of comorbidities for oppositional-defiant 
behavior, anxiety, depression, bipolar disorder, and other conditions, and it has 
also been observed that these children often have more psychopathology and social 
problems in the family [5]. These children are also at higher risk of taking various 
psychoactive substances, rejection from peers, poorer school achievement, rejection 
and the development of anxiety and depression in adolescence.
Many children with oppositional-defiant behavior also have conductive disor-
der, which is manifested by recurrent antisocial, aggressive, or defiant behavior. 
Study by Pliszka included 1035 children and adolescents at a psychiatric clinic 
and reported that 167 children and adolescents with ADHD were also diagnosed 
with oppositional defiant or conductive disorder [13]. Research demonstrated 
that 30–50% children with ADHD fulfill criteria for conduct disorder or oppo-
sitional defiant disorder [14]. These children are also at higher risk of substance 
abuse, antisocial activities, rejection from peers, school failure, anxiety and 
depression. The families of these children show more psychopathology and social 
problems.
2.2 Comorbidity with specific learning difficulties
These specific developmental disorders of school abilities include a group of 
disorders that are characterized by significant difficulties and impairments in 
mastering school skills, such as reading and arithmetic. These learning disabilities 
are not a direct result of other disorders such as mental retardation, neurological 
diseases, uncorrected vision or hearing disorders, or emotional disorders; although 
they may co-exist with them. Developmental disorders of school ability often exist 
in comorbidity with ADHD.
These disorders are thought to have arisen from abnormalities in cognitive 
processing that are mainly the result of some biological dysfunction; and are more 
common in boys than in girls. These children experience academic failure, often 
irregular schooling, difficulties in social adjustment and this is more pronounced in 
the later years of primary school or secondary school.
Specific learning difficulties are more common in people with ADHD than in the 
general population [15]. A meta-analysis of previous research has concluded that 
the prevalence is 45% [16]. These children have greater learning difficulties than 
children who have only specific learning difficulties.
Children with ADHD and specific learning difficulties have a problem process-
ing perceived information, difficulty reproducing words, sentences and letters, 
auditory discrimination, difficulty reproducing drawings (visual-motor discrimina-
tion), stringing letters, decoding letters or words [2]. Children with this comorbid-
ity will have lower academic achievement, poorer grades in school, will drop out 
of high school more often, and will continue their education after high school less 
often than their peers without ADHD [5].
2.3 Comorbidity with mood disorders
The main disorder in mood disorders is a change in mood or affect, in the sense 
of the presence of low mood or excessively good mood. A change in mood is usually 
accompanied by a change in the overall level of functioning. Most of these disorders 




Children and adolescents diagnosed with ADHD often have mood disorders at 
the same time, most commonly having major depressive disorder, depressive epi-
sodes, and bipolar disorder. Arnold et al. conducted a Longitudinal Assessment of 
Manic Symptoms and concluded that 60% of the sample met the criteria for ADHD, 
6.3% met the criteria for bipolar disorder, 16.5% had both ADHD and bipolar 
disorder. 17.5% do not have either of these two disorders [17]. Otherwise, the results 
of research in this area are uneven, so in population samples the prevalence is 0–2%, 
while in clinical samples it is 11–30% [18]. A special problem is the diagnosis, dif-
ferential diagnosis and treatment in children who have ADHD and mania. ADHD is 
more common in children, especially in boys, compared with bipolar disorder, which 
occurs in 1.8% of children and adolescents, and is somewhat more common in boys 
[19]. Comparing the symptoms of mania and ADHD, a high percentage of grandios-
ity is noticeable in mania (85%), while in ADHD it is only 6.7%. Elevated mood and 
bold behaviors occur in a high percentage in mania (87% and 79%, respectively), 
and in a very low in children with ADHD. Results from regression analyses suggest 
cognitive predictors of executive functioning impairment in ADHD and mood 
predictors for inhibition in pediatric bipolar disorder [20].
Comparing the symptoms between these two diseases in childhood, it is noticed 
that irritability is very pronounced in mania, and occasionally exists in ADHD; 
euphoria is excessive in mania, and situational in ADHD; children with ADHD have 
low self-esteem, while mania has a pronounced grandiosity; manic children have a 
reduced need for sleep, while children with ADHD resist going to bed but then sleep 
well; children with mania have a rapid flow of thought, while ADHD does not. In 
comorbidity, treatment preference is given to symptoms of high mood and therapy 
is primarily focused on mania (mood stabilizers or antipsychotics); while ADHD 
symptoms are treated secondarily, after mood stabilization.
One of the mood disorders that occurs in child psychiatry is depression. Studies 
in this area indicate that the prevalence of depression in children with ADHD is 
18%, and another 15% had both comorbid anxiety and depressive disorder [21]. 
The presence of depression worsens the symptoms and functioning of children with 
ADHD, and also significantly worsens the prognosis and therapeutic process in 
these children.
Adolescents who have a comorbidity of ADHD and depression have more 
pronounced difficulties in social functioning, get depression at an earlier age, have 
a higher rate of suicidal behavior, more frequent recurrence of depressive episodes 
compared to adolescents who suffer only from depression. Also, these adolescents 
have more frequent family dysfunction, more frequent conflicts in family relations, 
they have experienced more negative life events and traumatic experiences com-
pared to adolescents who have only ADHD.
2.4 Comorbidity with anxiety disorders
The prevalence of anxiety disorders in the general pediatric population is 
between 4% and 20%, while the prevalence of anxiety disorders in children with 
ADHD is 25% [22]. Clinical and epidemiological studies have shown that one-third 
of children with ADHD have some of the anxiety disorders at the same time. While 
some authors believe that there is no statistically significant difference between 
girls and boys in ADHD comorbidity and anxiety disorder, other authors state that 
17.6% of girls and 17.9% of boys have comorbid ADHD disease with anxiety or 
depressive disorder [8]. Children suffering from anxiety disorder have higher rates 
of ADHD [5].
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2.5 Comorbidity with the autism spectrum disorder (ASD)
Autism spectrum disorder refers to serious developmental disorders with 
specific patterns of communication and social interactions. These disorders have 
differences in the specificity and severity of symptoms, age of onset, level of 
functioning, and forms of social interactions.
Autistic children often have attention problems and information processing 
problems that lead to social deficits. In clinical samples, it is estimated that about 
10% of children tested for ADHD have some comorbid disorder from the autism 
spectrum disorder [9] characterized by more pronounced hyperactivity and impul-
sivity. ADHD is diagnosed in the autism spectrum disorder when the symptoms 
are very pronounced and permanent with the prior exclusion of medical and other 
psychiatric conditions that may mimic the symptoms of ADHD. In the treatment 
of ADHD comorbidities with autism spectrum disorder, the symptoms of both 
disorders must be treated.
2.6 Comorbidity with specific developmental speech and language disorders
In specific developmental disorders of speech and language, there is damage to 
the normal patterns of speech acquisition from the early stages of development. 
These disorders are often accompanied by associated problems such as reading 
difficulties and interpersonal relationships, emotional problems, and behavioral 
problems.
Some children who have ADHD also have language difficulties, which are 
present in both receptive and expressive language. There are also difficulties in 
other language skills. The results of research on the frequency of these comorbid 
diseases are different. Recent study estimated 50% of children with ADHD 
have a comorbid language deficit, while 20 to 60% of children with ADHD have 
one or more learning disabilities or language problems [23]. Study from 2016 
identified language impairments in the majority within the ADHD and reading 
disorder in >40% in children with ADHD [24]. A group of authors concluded in 
a 2013 study that children with ADHD exhibit various difficulties in pragmatic 
language [25].
2.7 Comorbidity with epilepsy
Epilepsy is a chronic brain disease characterized by recurrent epileptic seizures, 
accompanied by various clinical manifestations and laboratory abnormalities. 
Important features of epilepsy are chronicity and recurrence of excessive paroxys-
mal discharge of brain neurons that manifest as epileptic seizures.
Studies in children with ADHD have shown a significant risk of developing 
epilepsy and other seizures in these children. A study by a group of Norwegian 
authors in 2013 found that children with ADHD had 2.3% risk of epilepsy, which 
is four times higher than the general prevalence in children of 0.5% [26]. Previous 
research has also found a significant association between childhood ADHD and the 
risk of epilepsy. Epilepsy and ADHD are strongly associated although the underly-
ing factors contributing to their co-occurrence remain unclear [27]. The same study 
suggests that epilepsy and ADHD share less genetic risk factors as compared with 
other neurodevelopmental disorders.
Children with ADHD often have irregularities in EEG findings, and an increase 
in frontal-central theta-wave activity is most common [28].
ADHD
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2.8 Comorbidity with sleep disorders
Inorganic sleep disorders can also occur in children of any age. The most com-
mon sleep disorder in children is a sleep–wake cycle disorder, i.e. waking up during 
the night. This is also the most common reason that worries parents and why they 
seek professional help. The next most common disorder is when the child delays 
going to bed, cannot fall asleep when put to bed or when constantly asking for 
parental attention. Other sleep disorders are less common in children.
Children with ADHD often have difficulty sleeping in the form of frequent 
waking at night, resistance to going to sleep, they need to fall asleep for a long time. 
Sleep disorders are more likely to occur if children with ADHD also have some 
anxiety disorder compared to children who have only ADHD [29]. In observational 
study in a population of children with ADHD, 63% had moderate or severe sleep 
problems [30].
Parents of children with ADHD also report that children have difficulty sleeping, 
resist going to bed, sleep shorter, and often wake up at night. Parents describe these 
children as tired after waking up compared to children without ADHD [31]. Studies 
investigating event–related potential (ERP) suggest impaired ability in children with 
ADHD to conserve the brain oscillations phase associated with stimulus processing 
[32]. Children with ADHD presented more sleep disturbances when compared to 
children without the diagnosis. These disorders were diverse, yet inconsistent among 
the surveys [33].
2.9 Comorbidity with tic
Tic is a sudden, fast, involuntary, aimless and repetitive muscle movement, 
limited to a certain muscle group or accompanied by vocalization, which worsens 
in stressful situations and disappears during sleep. Tic disorders are divided into 
transient and chronic motor or vocal and Tourette’s syndrome. There is an irresist-
ible need to repeat the action, and its prevention causes tension. Tick disorders are 
associated with poor self-esteem, problems in the family environment, difficulties 
at school. Children and adolescents with tics have a number of other problems such 
as speech or behavior problems, impulsivity, hyperactivity, obsessive compulsive 
symptoms. The prevalence of transient and simple tics is 20% in the pediatric popu-
lation, and chronic motor tics and Tourette’s syndrome about 3% [34]. Children 
with ADHD were 4.1 times more likely to have chronic tic disorder at age 7, and 
5.9 times more likely at age 10 [35]. Children with ADHD and chronic tic disorder 
experienced higher rates of peer problems, and poorer quality of life than those 
with ADHD alone. Episodes of anger and aggression have been reported in children 
with tic disorders and are likely to contribute to psychosocial stress and low quality 
of life. It is assumed that aggressive behavior in children with tic disorders is associ-
ated with comorbid attention-deficit hyperactivity disorder [36].
2.10 Comorbidity with neuroophthalmological disorders
Ophthalmological examination of children and adolescents with ADHD is part 
of their evaluation as it is important to rule out underlaying ocular and neurologi-
cal conditions that may cause behavioral aberrations. Some children with visual 
impairment may be misdiagnosed as ADHD. These children are not able to see 
adequately and in result are not able to keep their attention being focused on object 
of observation. To our knowledge, there are small number of studies investigating 
the relationship between ADHD and ocular disorders such as amblyopia, hyperme-
tropia, astigmatism, and heterotropia. Children with amblyopia have greater risk 
9
Comorbidity in Children and Adolescents with ADHD
DOI: http://dx.doi.org/10.5772/intechopen.94527
of developing ADHD than their counterparts without amblyopia (1,8 times; hazard 
ratio 1.81; 95% confidence interval 1.59–2.06) with the greatest risk in amblyopic 
children with deprivation type, followed by strabismic type and refractive type 
(hazard ratio 2.14; 95% confidence interval 1.56–2.92; hazard ratio 2.09; 95% 
confidence interval 1.15–3.79; hazard ratio 1.76; 95% confidence interval 1.54–2.02 
respectively). Also, amblyopic children with ADHD tend to be diagnosed at younger 
age than those without amblyopia (median 8.14 vs. 8.45 years; P = 0.0096) [37].
Large cross-sectional study on 75,171 children without any intellectual impair-
ment reported greater prevalence of ADHD among children with vision problems 
(p < 0.0001). Children with vision problems were more likely to have been diag-
nosed with ADHD than those without vision problems (15.6% vs. 8.3%; p < 0.001). 
Children with vision problems were also more likely to have ever been diagnosed 
with ADHD (18.6% vs. 10.4%; p < 0.001) [38].
Another large-scale cross-sectional study on 116,308 children with ADHD 
reported significant higher prevalence of ocular disorder in children with ADHD 
compared to children without ADHD: amblyopia (1.6% vs. 0.9%, p < 0.001), 
hypermetropia (2.4% vs. 1.3%, p < 0.001), astigmatism (0.2% vs. 0.1%, p < 0.001), 
and heterotropia (1.1% vs. 0.5%, p < 0.001) respectively [39].
Recent studies investigated relationship between ADHD and convergence 
insufficiency as symptoms of convergence insufficiency may overlap with those of 
ADHD. Within population of children with convergence insufficiency, three-fold 
greater incidence of ADHD is reported compared to ADHD incidence in general 
population. Also ADHD population had three-fold greater incidence of convergence 
insufficiency [40]. Children with ADHD had significant low near point conver-
gence as well [41].
2.11 Treatment of comorbidities
Comorbid diseases often occur in children and adolescents with ADHD. It is 
estimated that about 66% of ADHD patients have at least one comorbid disorder, 
and the most common are learning disorders, sleep disorders, oppositional defiant 
disorder and anxiety disorders [42]. Treating children and adolescents with ADHD 
who have comorbid conditions is a challenge for clinicians [43].
When it is necessary to include medications in children with ADHD, existing 
guidelines suggest starting with a stimulant (methylphenidate MPH or amphetamine 
AMP). If the stimulant does not achieve an effect then an alternative stimulant is 
used. If stimulants are not effective or cause more severe side effects, we include 
nonstimulants (atomoxetine, alpha-2 agonists, and antidepressants) [44]. Stimulants 
have been approved by the Food and Drug Administration (FDA) in the treatment 
of ADHD, including methylphenidate and dextroamphetamine and amphetamine 
mixed salts, and these drugs act by blocking the reuptake of dopamine and nor-
epinephrine into neurons. Side effects including insomnia, headache, changes in 
appetite, weight loss/gain, irritability and tics should be monitored during treatment 
with stimulants. Stimulants are the first line in treatment. Non-stimulants (atom-
oxetine, alpha-2 agonists, and antidepressants) are less effective than stimulants. 
Children with complicated epilepsy may be at greater risk for ADHD, and some 
antiepileptic medications may contribute to ADHD symptoms. Tricyclic antidepres-
sants have been used in children with ADHD but can lower seizure threshold and 
should be avoided in patients with epilepsy. Methylphenidate is effective in treating 
the symptoms of ADHD in children and adolescents with epilepsy, but the effective-
ness is less than that seen in children with ADHD without epilepsy [44].
The comorbidity of ADHD with bipolar disorder (BD) may be associated with 
more severe symptoms, poorer course, and poor outcome of both conditions, and 
ADHD
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treatment is further complicated if there is substance abuse [45]. The use of stimu-
lants may be contraindicated in the presence of comorbid drug abuse. Atomoxetine 
may be effective in treating the symptoms of ADHD in patients with bipolar 
disorder when used in conjunction with mood stabilizers.
In children with ADHD comorbidities and sleep problems, sleep hygiene and 
cognitive-behavioral psychotherapy are important, and consideration should be 
given to changing the dosage and formulation of the stimulant. The use of atomox-
etine and melatonin are therapeutic alternatives for children with ADHD and more 
severe sleep problems [46].
Psychopharmacology is the primary treatment for ADHD, and behavioral treat-
ment is used in combination with medication or in children with minimal impairment 
or when medication is not possible due to contraindications or parents ‘refusal to accept 
medication. Most guidelines recommend a stepwise approach to treatment, begin-
ning with non-drug interventions and then moving to pharmacological treatment in 
those most severely affected [47]. In large birth cohort study, where a great majority 
of children with ADHD used medication, only child characteristics were significantly 
associated with the use of medication [48]. In this study the authors concluded that 
the small differences between medicated and unmedicated children, might be due to 
strong established clinical practices where medication is offered as a treatment option, 
particularly for hyperkinetic conduct disorder in an egalitarian high-income society.
In a large meta-analysis that included 38 individual studies with 5111 partici-
pants aged 3 to 18 years, the authors concluded that methylphenidate may improve 
teacher-reported ADHD symptoms, teacher-reported general behavior, and 
parent-reported quality of life among children and adolescents diagnosed with 
ADHD [49].
Treatment of comorbid diseases in children with ADHD should be multimodal, 
including pharmacological and nonpharmacological interventions. It is important 
to recognize the presence of comorbid disease in these children because comorbid 
diseases complicate the diagnostic and therapeutic process, as well as the outcome 
of the disease.
3. Conclusion
Attention Deficit Hyperactivity Disorder is a neurobiological disorder that 
involves the interaction of the neuroanatomical and neurotransmitter systems. 
This disorder is characterized by early onset, the association of hyperactive and 
poorly coordinated behavior with marked inattention and lack of perseverance in 
performing tasks; and this behavior occurs in all situations and persists over time. 
Most children and adolescents with Attention Deficit Hyperactivity Disorder have 
comorbidities, often multiple comorbid conditions in the same person. It is esti-
mated that about two-thirds of children with this disorder have at least one other 
psychiatric disorder diagnosed. Symptoms persist and lead to significant difficulties 
in the daily functioning of the child, such as school success, social interactions, 
family and social functioning. The presence of comorbidities is significant because 
it complicates the diagnostic process, affects the course, prognosis and therapeutic 
process. Assessment and support in comorbid disorders are often as important as 
the assessment and treatment of ADHD symptoms.
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